 |
 |

Patterns of Brain Atrophy That Differentiate Corticobasal Degeneration Syndrome From Progressive Supranuclear Palsy
Adam L. Boxer, MD, PhD;
Michael D. Geschwind, MD, PhD;
Nataliya Belfor, PhD;
Maria Luisa Gorno-Tempini, MD, PhD;
Guido F. Schauer, BSc;
Bruce L. Miller, MD;
Michael W. Weiner, MD;
Howard J. Rosen, MD
Arch Neurol. 2006;63:81-86.
Background Progressive brain atrophy is associated with the corticobasal degeneration syndrome (CBDS) and progressive supranuclear palsy (PSP). Regional differences in brain atrophy may reflect the clinical features of disease.
Objective To quantify the structural neuroanatomical differences between CBDS and PSP.
Design A survey of neurologic deficits was conducted in all patients. Voxel-based morphometry was used to quantify structural neuroanatomical differences on magnetic resonance images in each subject group.
Setting University hospital dementia clinic.
Participants Fourteen patients who met clinical research criteria for CBD and 15 patients who met clinical research criteria for PSP, who were matched for severity of disease, age, and functional status, and 80 age-matched control subjects.
Main Outcome Measures Statistically significant differences in regional gray and white matter volume, after multiple comparisons correction, between groups of subjects.
Results The patients with CBDS displayed an asymmetric (left > right) pattern of brain atrophy that involved the bilateral premotor cortex, superior parietal lobules, and striatum. Progressive supranuclear palsy was associated with atrophy of the midbrain, pons, thalamus, and striatum, with minimal involvement of the frontal cortex. Midbrain structures were more atrophied in PSP than in CBD, whereas dorsal frontal and parietal cortices were more atrophied in CBD than in PSP. The degree of atrophy of the midbrain and pontine tegmentum and the left frontal eye field differentiated the 2 patient groups with 93% accuracy.
Conclusions Distinct patterns of brain atrophy exist in CBDS and PSP that can be used to differentiate the 2 diseases. Assessments of brain atrophy in these disorders should be focused on cortical and brainstem ocular motor control areas.
Author Affiliations: Memory and Aging Center, Department of Neurology, University of California, San Francisco (Drs Boxer, Geschwind, Belfor, Gorno-Tempini, Miller, and Rosen and Mr Schauer); and Magnetic Resonance Spectroscopy Unit, San Francisco Veterans Administration Hospital (Drs Boxer and Weiner).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
Borroni et al.
Neurology 2008;71:1796-1803.
ABSTRACT
| FULL TEXT
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease
Rizzo et al.
Brain 2008;131:2690-2700.
ABSTRACT
| FULL TEXT
White Matter Changes in Corticobasal Degeneration Syndrome and Correlation With Limb Apraxia
Borroni et al.
Arch Neurol 2008;65:796-801.
ABSTRACT
| FULL TEXT
Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease
Garbutt et al.
Brain 2008;131:1268-1281.
ABSTRACT
| FULL TEXT
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations
Chen-Plotkin et al.
Neurology 2008;70:521-527.
ABSTRACT
| FULL TEXT
Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration
Rabinovici et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2008;22:474-488.
ABSTRACT
Deformation-Based Morphometry Reveals Brain Atrophy in Frontotemporal Dementia
Cardenas et al.
Arch Neurol 2007;64:873-877.
ABSTRACT
| FULL TEXT
Rates of cerebral atrophy differ in different degenerative pathologies
Whitwell et al.
Brain 2007;130:1148-1158.
ABSTRACT
| FULL TEXT
Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy
O'Keeffe et al.
Brain 2007;130:753-764.
ABSTRACT
| FULL TEXT
Mixing pro- and antisaccades in patients with parkinsonian syndromes
Rivaud-Pechoux et al.
Brain 2007;130:256-264.
ABSTRACT
| FULL TEXT
Structural anatomy of empathy in neurodegenerative disease
Rankin et al.
Brain 2006;129:2945-2956.
ABSTRACT
| FULL TEXT
|